tiprankstipranks
Bruker Corporation (MX:BRKR)
NASDAQ:BRKR
Mexico Market
BRKR
Bruker
RESEARCH TOOLSreports

Bruker (BRKR) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BRKR Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
4 Buy
5 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Bruker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BRKR Stock 12 Month Forecast

Average Price Target

$987.93
Based on 10 Wall Street analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is $987.93 with a high forecast of $1,220.38 and a low forecast of $697.36. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"611":"$611","916":"$916","1221":"$1,221","763.5":"$763.5","1068.5":"$1,068.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1220.3838976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.22K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":987.9298218666668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$987.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":697.3622272,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$697.36</span>\n  </div></div>","useHTML":true}}],"tickPositions":[611,763.5,916,1068.5,1221],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,744.6449152,784.2898304,823.9347456,863.5796608,903.2245760000001,942.8694912,982.5144064,1022.1593216,1061.8042368000001,1101.4491520000001,1141.0940672,1180.7389824,{"y":1220.3838976,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,726.763832451282,748.5276649025641,770.2914973538461,792.0553298051283,813.8191622564103,835.5829947076924,857.3468271589744,879.1106596102564,900.8744920615386,922.6383245128206,944.4021569641027,966.1659894153847,{"y":987.9298218666668,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,704.4124790153846,703.8249580307693,703.2374370461539,702.6499160615384,702.062395076923,701.4748740923077,700.8873531076923,700.299832123077,699.7123111384616,699.1247901538461,698.5372691692307,697.9497481846154,{"y":697.3622272,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":726.168,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":726.168,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":617.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":612.675,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":712.297,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":702.335,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,220Average Price Target$987.93Lowest Price Target$697.36
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:BRKR
Evie Koslosky
Goldman Sachs
Goldman Sachs
$610.19→$697.36
Sell
―
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), Bruker (NASDAQ: BRKR) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
TD Cowen Analyst forecast on MX:BRKR
Daniel Brennan
TD Cowen
TD Cowen
$784.53→$1,046.04
Hold
―
Reiterated
07/15/26
Bruker price target raised to $60 from $45 at TD CowenBruker price target raised to $60 from $45 at TD Cowen
Citi Analyst forecast on MX:BRKR
Patrick B Donnelly
Citi
Citi
$767.1→$1,046.04
Hold
―
Reiterated
07/08/26
Bruker price target raised to $60 from $44 at CitiBruker price target raised to $60 from $44 at Citi
Guggenheim Analyst forecast on MX:BRKR
Subbu Nambi
Guggenheim
Guggenheim
$871.7→$1,220.38
Buy
―
Reiterated
06/29/26
Bruker price target raised to $70 from $50 at GuggenheimBruker price target raised to $70 from $50 at Guggenheim
Barclays Analyst forecast on MX:BRKR
Luke Sergott
Barclays
Barclays
$924→$1,046.04
Buy
―
Assigned
06/24/26
Barclays Sticks to Their Buy Rating for Bruker (BRKR)
J.P. Morgan Analyst forecast on MX:BRKR
Casey Woodring
J.P. Morgan
J.P. Morgan
$784.53→$1,133.21
Buy
―
Reiterated
06/08/26
Bruker price target raised to $65 from $45 at JPMorganBruker price target raised to $65 from $45 at JPMorgan
Bank of America Securities Analyst forecast on MX:BRKR
Michael Ryskin
Bank of America Securities
Bank of America Securities
$854.27→$1,133.21
Buy
―
Reiterated
06/02/26
Bruker (BRKR) Receives a Buy from Bank of America Securities
Wolfe Research Analyst forecast on MX:BRKR
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
06/01/26
Bruker assumed at Peer Perform from Outperform at Wolfe ResearchBruker assumed at Peer Perform from Outperform at Wolfe Research
Stifel Nicolaus Analyst forecast on MX:BRKR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$697.36→$784.53
Hold
―
Assigned
05/08/26
Bruker price target raised to $45 from $40 at StifelBruker price target raised to $45 from $40 at Stifel
RBC Capital Analyst forecast on MX:BRKR
Dan Leonard
RBC Capital
RBC Capital
$697.36→$784.53
Hold
―
Assigned
05/07/26
Bruker price target raised to $45 from $40 at UBSBruker price target raised to $45 from $40 at UBS
Jefferies Analyst forecast on MX:BRKR
Tycho Peterson
Jefferies
Jefferies
$958.87→$871.7
Buy
―
Reiterated
02/12/26
Bruker price target lowered to $50 from $55 at JefferiesBruker price target lowered to $50 from $55 at Jefferies
Wells Fargo Analyst forecast on MX:BRKR
Brandon Couillard
Wells Fargo
Wells Fargo
$836.83→$958.87
Buy
―
Reiterated
12/15/25
Bruker price target raised to $55 from $48 at Wells FargoBruker price target raised to $55 from $48 at Wells Fargo
Rothschild & Co Redburn Analyst forecast on MX:BRKR
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,046.04
Buy
―
Reiterated
11/20/25
Bruker initiated with a Buy at Rothschild & Co RedburnBruker initiated with a Buy at Rothschild & Co Redburn
Nephron Analyst forecast on MX:BRKR
Jack Meehan
Nephron
Nephron
―
Hold
―
Upgraded
11/03/25
Bruker upgraded to Hold from Sell at Nephron ResearchBruker upgraded to Hold from Sell at Nephron Research
Leerink Partners Analyst forecast on MX:BRKR
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/07/25
Bruker Positioned for Recovery and Growth Amid Financial Maneuvering and Strategic Initiatives
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:BRKR
Evie Koslosky
Goldman Sachs
Goldman Sachs
$610.19→$697.36
Sell
―
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), Bruker (NASDAQ: BRKR) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
TD Cowen Analyst forecast on MX:BRKR
Daniel Brennan
TD Cowen
TD Cowen
$784.53→$1,046.04
Hold
―
Reiterated
07/15/26
Bruker price target raised to $60 from $45 at TD CowenBruker price target raised to $60 from $45 at TD Cowen
Citi Analyst forecast on MX:BRKR
Patrick B Donnelly
Citi
Citi
$767.1→$1,046.04
Hold
―
Reiterated
07/08/26
Bruker price target raised to $60 from $44 at CitiBruker price target raised to $60 from $44 at Citi
Guggenheim Analyst forecast on MX:BRKR
Subbu Nambi
Guggenheim
Guggenheim
$871.7→$1,220.38
Buy
―
Reiterated
06/29/26
Bruker price target raised to $70 from $50 at GuggenheimBruker price target raised to $70 from $50 at Guggenheim
Barclays Analyst forecast on MX:BRKR
Luke Sergott
Barclays
Barclays
$924→$1,046.04
Buy
―
Assigned
06/24/26
Barclays Sticks to Their Buy Rating for Bruker (BRKR)
J.P. Morgan Analyst forecast on MX:BRKR
Casey Woodring
J.P. Morgan
J.P. Morgan
$784.53→$1,133.21
Buy
―
Reiterated
06/08/26
Bruker price target raised to $65 from $45 at JPMorganBruker price target raised to $65 from $45 at JPMorgan
Bank of America Securities Analyst forecast on MX:BRKR
Michael Ryskin
Bank of America Securities
Bank of America Securities
$854.27→$1,133.21
Buy
―
Reiterated
06/02/26
Bruker (BRKR) Receives a Buy from Bank of America Securities
Wolfe Research Analyst forecast on MX:BRKR
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
06/01/26
Bruker assumed at Peer Perform from Outperform at Wolfe ResearchBruker assumed at Peer Perform from Outperform at Wolfe Research
Stifel Nicolaus Analyst forecast on MX:BRKR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$697.36→$784.53
Hold
―
Assigned
05/08/26
Bruker price target raised to $45 from $40 at StifelBruker price target raised to $45 from $40 at Stifel
RBC Capital Analyst forecast on MX:BRKR
Dan Leonard
RBC Capital
RBC Capital
$697.36→$784.53
Hold
―
Assigned
05/07/26
Bruker price target raised to $45 from $40 at UBSBruker price target raised to $45 from $40 at UBS
Jefferies Analyst forecast on MX:BRKR
Tycho Peterson
Jefferies
Jefferies
$958.87→$871.7
Buy
―
Reiterated
02/12/26
Bruker price target lowered to $50 from $55 at JefferiesBruker price target lowered to $50 from $55 at Jefferies
Wells Fargo Analyst forecast on MX:BRKR
Brandon Couillard
Wells Fargo
Wells Fargo
$836.83→$958.87
Buy
―
Reiterated
12/15/25
Bruker price target raised to $55 from $48 at Wells FargoBruker price target raised to $55 from $48 at Wells Fargo
Rothschild & Co Redburn Analyst forecast on MX:BRKR
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,046.04
Buy
―
Reiterated
11/20/25
Bruker initiated with a Buy at Rothschild & Co RedburnBruker initiated with a Buy at Rothschild & Co Redburn
Nephron Analyst forecast on MX:BRKR
Jack Meehan
Nephron
Nephron
―
Hold
―
Upgraded
11/03/25
Bruker upgraded to Hold from Sell at Nephron ResearchBruker upgraded to Hold from Sell at Nephron Research
Leerink Partners Analyst forecast on MX:BRKR
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/07/25
Bruker Positioned for Recovery and Growth Amid Financial Maneuvering and Strategic Initiatives
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bruker

3 Months
Luke SergottBarclays
Success Rate
8/15 ratings generated profit
53%
Average Return
+2.47%
Copying Luke Sergott's trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of +2.47% per trade.
1 Year
Luke SergottBarclays
Success Rate
11/15 ratings generated profit
73%
Average Return
+25.43%
Copying Luke Sergott's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +25.43% per trade.
2 Years
Luke SergottBarclays
Success Rate
14/15 ratings generated profit
93%
Average Return
+39.75%
Copying Luke Sergott's trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +39.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BRKR Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
1
0
0
0
Buy
12
10
8
7
6
Hold
7
5
5
6
7
Sell
1
1
0
0
2
Strong Sell
0
0
0
0
0
total
21
17
13
13
15
In the current month, BRKR has received 6 Buy Ratings, 7 Hold Ratings, and 2 Sell Ratings. BRKR average Analyst price target in the past 3 months is 987.93.
Each month's total comprises the sum of three months' worth of ratings.

BRKR Financial Forecast

BRKR Earnings Forecast

Next quarter’s earnings estimate for BRKR is $6.71 with a range of $6.35 to $6.97. The previous quarter’s EPS was $5.40. BRKR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.
Next quarter’s earnings estimate for BRKR is $6.71 with a range of $6.35 to $6.97. The previous quarter’s EPS was $5.40. BRKR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.

BRKR Sales Forecast

Next quarter’s sales forecast for BRKR is $14.88B with a range of $14.69B to $15.11B. The previous quarter’s sales results were $14.36B. BRKR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.
Next quarter’s sales forecast for BRKR is $14.88B with a range of $14.69B to $15.11B. The previous quarter’s sales results were $14.36B. BRKR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.

BRKR Stock Forecast FAQ

What is MX:BRKR’s average 12-month price target, according to analysts?
Based on analyst ratings, Bruker Corporation’s 12-month average price target is 987.93.
    What is MX:BRKR’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:BRKR, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Bruker Corporation a Buy, Sell or Hold?
        Bruker Corporation has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.
          What is Bruker Corporation’s share price target?
          The average share price target for Bruker Corporation is 987.93. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,220.38 ,and the lowest forecast is $697.36. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Bruker Corporation?
            Bruker Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Bruker Corporation?
              To buy shares of MX:BRKR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.